Advertisement
U.S. Markets open in 6 hrs 45 mins

Orgenesis Inc. (ORGS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
1.2000-0.0800 (-6.25%)
At close: 03:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.2800
Open1.2300
Bid1.1800 x 40000
Ask1.2100 x 40000
Day's Range1.1900 - 1.2600
52 Week Range1.0300 - 10.8000
Volume3,364
Avg. Volume38,655
Market Cap5.725M
Beta (5Y Monthly)1.21
PE Ratio (TTM)N/A
EPS (TTM)-8.0000
Earnings DateNov 11, 2024 - Nov 15, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Orgenesis Commences Trading on OTCQX® Best Market

    Reports Plans to Reapply for Nasdaq Listing Announces Progress Advancing Decentralized Cell Processing Platform GERMANTOWN, Md., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) in order to improve access and outcomes in healthcare, today announced that its common stock will begin trading on the OTCQX® Best Market under the ticker symbol "ORGS" following i

  • GlobeNewswire

    Orgenesis Announces Reverse Stock Split

    GERMANTOWN, Md., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) (“Orgenesis” or the “Company”) today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company’s common stock, par value $0.0001, which will be effective at 5:00 pm Eastern Time on September 24, 2024. The Company’s common stock will continue to be traded on The Nasdaq Capital Market on a split-adjusted basis beginning on September 25, 2024, under the Company’s existing trading